Plunkett Research Online: Amarin Corporation plc

AMARIN CORPORATION PLC (AMRN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa......



Amarin Corporation plc
Ticker: AMRN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 353 1 6699 020
Fax:
Address: 77 Sir John Rogerson’s Quay
Block C
Grand Canal Docklands
Dublin, D02 VK60 Ireland

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs, Cardiovascular
Drugs, Cardiovascular Health
Drugs, Triglyceride Reduction
Pharmaceutical Development
Contacts Description
Michael Kalb Assistant Secretary/CFO/Chief Accounting Officer/Senior VP
Karim Mikhail CEO/Director/President
See More
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa......See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2021 2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Vascepa
VAZKEPA
REDUCE-IT
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: